Statistics for Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

Total visits

views
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. 35

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

File Visits

views
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4) a randomised, double-blind, double placebo-c.pdf 18